VT News
Luka Mkheidze

Luka Mkheidze

Ask VT AI
View News Summary
  • Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
  • Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
  • Teenage Saracens winger Noah Caluori earns surprise England call-up after impressive Premiership debut.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
  • Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
  • Teenage Saracens winger Noah Caluori earns surprise England call-up after impressive Premiership debut.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Luka Mkheidze

Top Topics

Trending in U.S.

World

Sport